Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion

Technology appraisal guidance
Reference number: TA305
Published: 26 February 2014

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: final appraisal determination document

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: final appraisal determination document

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: final appraisal determination document
31 December 2013
(364.44 Kb 46 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 20 December 2013